GOVX: GeoVax Labs Kompaniya qiymatining sof foydaga nisbati
GeoVax Labs, Inc. (GOVX) bozor dinamikasi uning kuchli ilmiy obro'ga ega bo'lgan onkologiya va yuqumli kasalliklar uchun ilg'or davolash vositalarini ishlab chiquvchi maqomini ta'kidlaydi. Jori ko'rsatkich 0.00 darajasida turibdi. Biznesning o'sishi MVA texnologiyasiga tayanadi, asosiy stimulyatorlar esa hukumat subsidiyalari hamda chechak va COVID-19ga qarshi dori vositalarining sinov natijalari hisoblanadi. Klinik sinovlarni muvaffaqiyatli olib borayotgan vakolatli rahbariyat investorlarning yuqori ishonchini ta'minlamoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_GOVX_-_GeoVax-Labs-Inc._-_PE-Multiple "GOVX: GeoVax Labs, Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 15.11.2026 | 👁️GURU.Markets👁️")
GeoVax Corp (GOVX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati GeoVax Labs, Inc.|GOVX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati geovax.com|GOVX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati GeoVax Labs, Inc.|GOVX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz GeoVax|Kritik likvidlik geovax.com
- foyda va bozor multiplikatorlari tafsilotlari:
GOVX - Sof foyda|Kutilayotgan sof foyda GeoVax Labs, Inc.|GOVX - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati GeoVax Labs, Inc.|GOVX - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati GeoVax Labs, Inc.|GOVX - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) GeoVax|GOVX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi geovax.com|GOVX - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi GeoVax Labs, Inc.
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:GeoVax GOVX
GeoVax Labs, Inc. (GOVX) kompaniyasining operatsion yutuqlarini uning tarixiy P/E koeffitsiyenti orqali tahlil qilish biznesning bozor qiymatini yillik sof foydaga nisbatan baholash imkonini beradi. Ushbu koeffitsiyent investitsiyalarning qoplanish muddatini o'lchasa-da, biotexnologiya sektorida u ko'pincha spekulyativ kutishlarning ko'rsatkichi bo'lib xizmat qiladi va klinik sinovlar natijalariga erisha olmaslik xavflari hamda tashqi davlat moliyalashtirilishiga bo'lgan bog'liqlikni aks ettiradi.
Muhim raqobatchilar
P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Narx-foyda koeffitsiyenti|Grifols Biemat (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotechnologies|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori auriniapharma.com|Narxning foydaga nisbati BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Narx-foyda multiplikatori|P/E multiplikatori DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Biologics - P/E multiplikatori|tourmalinebio.com - Bozor narxining sof foydaga nisbati|Precigen (PGEN) - Narxning foydaga nisbati|Pharming Group - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Nektar Therapeutics Inc|UPB (Upstream Pharma) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ZBIO|P/E multiplikatori immunome.com (IMNM)|P/E multiplikatori GOSS (gossamerbio.com)|Biznesning o‘zini qoplash muddati KalVista Pharma (KALV)|SEPN - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - P/E multiplikatori|ATXS (Astria Therapeutics, Inc.) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics, Inc - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati TLSA|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Ventyx Bio|Narxning foydaga nisbati Theratechnologies, Inc.|Kapitalizatsiyaning foydaga nisbati Avalo Therapeutics AVTX|P/E multiplikatori ELDN|AGEN (Agenus, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Kapitalizatsiyaning foydaga nisbati|ATYR: Narx-foyda koeffitsiyenti|adagene.com (ADAG) - Narx-foyda koeffitsiyenti|Ikena Oncology (IMA) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Shattuck Labs, Inc.|Narxning foydaga nisbati equilliumbio.com|Narx-foyda koeffitsiyenti connectbiopharm.com (CNTB)|P/E multiplikatori IMUX|Biznesning o‘zini qoplash muddati Atara Bio|Narxning foydaga nisbati InflaRx N.V. IFRX|X4 Pharmaceuticals - Narxning foydaga nisbati|ACET: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CELU (celularity.com)|INMB: P/E multiplikatori|BRNS: Bozor narxining sof foydaga nisbati|KZR (Kezar Life Sciences, Inc.) - P/E multiplikatori|SAB Biotherapeutics Inc. (SABS) - Biznesning o‘zini qoplash muddati|P/E multiplikatori AKTX|Narxning foydaga nisbati ENLV (Enlivex Therapeutics Ltd)|Narxning foydaga nisbati Q32 Bio Inc. QTTB|P/E multiplikatori edesabiotech.com EDSA|iBio Corporation - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CARM (carismatx.com)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Bio (BOLT) - P/E multiplikatori|HCWB (HCW Biologics Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Aptevo Therapeutics (APVO)|P/E multiplikatori AIM|Bozor narxining sof foydaga nisbati ADTX|P/E multiplikatori GRI (GRI Bio Corporation)|P/E multiplikatori XORTX Corp XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Scinai Immunotherapeutics Ltd (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori
